Immunohistochemistry for the Prion Protein: Comparison of Different Monoclonal Antibodies in Human Prion Disease Subtypes-Reference-Cited by-同舟云学术

Immunohistochemistry for the Prion Protein: Comparison of Different Monoclonal Antibodies in Human Prion Disease Subtypes

Published:2006-04-05 Issue:1 Volume:12 Page:1-11
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:

Author:

Kovács Gábor G.,Head Mark W.,Hegyi Ivan,Bunn Tristan J.,Flicker Helga,Hainfellner Johannes A.,McCardle Linda,László Lajos,Jarius Christa,Ironside James W.,Budka Herbert

Publisher

Wiley

Subject

Clinical Neurology,Pathology and Forensic Medicine,General Neuroscience

Reference29 articles.

1. Fatal familial insomnia: a new Austrian family;Almer;Brain,1999

2. Prion protein immunocytochemistry-UK five centre consensus report;Bell;Neuropathol Appl Neurobiol,1997

3. The use of monoclonal antibodies in human prion disease;Bodemer;Naturwissenschaften,1999

4. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases);Budka;Brain Pathol,1995

5. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD;Collinge;Nature,1996

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative analysis of prion disease using an AI-powered digital pathology framework;Scientific Reports;2023-10-18

2. Tailored behavioural tests reveal early and progressive cognitive deficits in M1000 prion disease;Neurobiology of Disease;2023-05

3. Molecular Mechanisms Encoding Strains of Prions and Prion-Like Misfolded Proteins;Prions and Diseases;2023

4. Chronological Changes in the Expression Pattern of Hippocampal Prion Proteins During Disease Progression in Sporadic Creutzfeldt-Jakob Disease MM1 Subtype;Journal of Neuropathology & Experimental Neurology;2022-09-05

5. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease;Acta Neuropathologica Communications;2022-08-17